Psychiatrists ascribe the highest level of unmet need in insomnia treatment to be for new therapies with a reduced risk of abuse and tolerance, according to a recent Decision Resources Group’s report on insomnia.
Sleeping pills and anti-anxiety drugs and have been linked to an increased risk of death, according to new research from the University of Warwick. The large study, published in BMJ, shows that several anxiolytic (anti-anxiety) drugs or hypnotic drugs (sleeping pills) are associated with a doubling in the risk of mortality.
NBC affiliate 13WTHR (Indiana) recently featured a clinical trial on a light therapy to treat early awakening insomnia.
The Taipei Times reports on new research by the Taiwan Society of Sleep Medicine. Nearly one in two Taiwanese 65 or older has trouble sleeping at least once a week and about 25 percent of them suffer from chronic insomnia, new research by the Taiwan Society of Sleep Medicine shows.
Seattle-based television station King5 recently did a segment on a clinical trial in which asthma patients are using CPAP devices.
Wake Up Narcolepsy (WUN) will be represented by 14 dedicated individuals from across the United States and Canada in the 118th Boston Marathon. WUN is a nonprofit organization working to speed narcolepsy diagnosis and treatment and fund medical research to find a cure.
Most genes involved in the regulation of the circadian clock have been characterized, but Akihiro Goriki, Toru Takumi, and their colleagues from RIKEN and Hiroshima University in Japan and the University of Michigan in the United States knew that a key component was missing and sough to uncover it in mammals.
A diagnosis of obstructive sleep apnea (OSA) may raise the risk of osteoporosis, particularly among women or older individuals, according to a new study.
In response to concerns from the aviation medical community, the Federal Aviation Administration (FAA) earlier this month sent draft guidance for Aviation Medical Examiners (AMEs) on obstructive sleep apnea (OSA) to industry medical representatives to review. Untreated OSA has always been and will continue to be a disqualifying medical condition, the agency reiterated.
Research and Markets added the “Global Sleep Apnea Diagnostic and Therapeutic Devices Market Report” to its offering. The analysts forecast the global sleep apnea diagnostic and therapeutic devices market to grow at a compound annual growth rate of 16.37% over the period 2012 to 2016.